Cambridge Investment Research Advisors’s Avantis US Equity ETF AVUS Stock Holding History
Bought
Maintained
Sold
Other funds holding AVUS
HWM
ORL
MPW
AAS
FPI
Cambridge Investment Research Advisors's AVUS Position: Q1 2026 in Review
Cambridge Investment Research Advisors increased its Avantis US Equity ETF (AVUS) stake by 0.36% in Q1 2026, buying an estimated $14.3K and bringing the position to 35,310 shares worth $3.93M. The position accounts for 0.01% of the portfolio, ranked #1110.
Cambridge Investment Research Advisors first reported a position in AVUS in Q3 2021 and has held it in 19 quarters since. The position peaked at $11M in Q2 2022. 553 funds tracked by Wall St. Rank hold AVUS as of Q1 2026.
- Cambridge Investment Research Advisors held 35,310 shares of Avantis US Equity ETF worth $3.93M as of Q1 2026.
- Cambridge Investment Research Advisors bought 125 Avantis US Equity ETF shares in Q1 2026, an estimated $14.3K.
- Avantis US Equity ETF made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #1110 holding.
- Cambridge Investment Research Advisors first reported a position in Avantis US Equity ETF in Q3 2021 and has held it in 19 quarters since.
- Cambridge Investment Research Advisors's Avantis US Equity ETF position peaked at $11M in Q2 2022.
- 553 funds tracked by Wall St. Rank held Avantis US Equity ETF as of Q1 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.